OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Some of the billionaire tech CEOs (aka the 'broligarchy') who now support Trump also seem to have adopted parts of his ...
Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion ...
We recently published a list of 10 AI Stocks Investors are Watching Closely. In this article, we are going to take a look at ...
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...